Skip to main content

Ncardia DiscoverHit Drug Screening Platform

Ncardia has launched the DiscoverHit drug screening platform, a service intended to help researchers access disease-relevant biology earlier in the drug-discovery process. DiscoverHit is a phenotypic drug screening platform comprising genetic and induced human pluripotent stem cell-derived cardiac and neural disease models; controlled bioreactor-based manufacturing to enable batch sizes compatible with high-throughput screening; customized development of disease-relevant assays; and high-throughput screening combined with high-content data acquisition and analysis.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.